Experimental virus therapy takes on deadly brain cancer
Disease control
Recruiting now
This early-phase trial is testing a new treatment for glioblastoma, an aggressive brain cancer. The therapy uses a modified virus (RZ-001) that is injected into the tumor, followed by an antiviral drug (valganciclovir) designed to activate the virus and kill cancer cells. The stu…
Phase: PHASE1, PHASE2 • Sponsor: Rznomics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:50 UTC